Professor Anthony Rodgers has played an internationally recognised role in measuring major risks to health, being appointed by WHO to author their annual report. He co-initiated numerous landmark studies in cardiovascular disease prevention/treatment, including the Asia Pacific Cohort Studies Collaboration, involving more than 50 studies and 600,000 participants.
Rodgers also developed the first m-Health smoking cessation program. Now part of the WHO/ITU initiative ‘Be healthy, be mobile’, most recently in 2016 enrolling over 2 million participants in India. Finally, he led development and testing of affordable cardiovascular combination pills (“polypills”), leading an international trials program and public-private partnerships.